{"nct_id":"NCT05024747","title":"A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers","status":"COMPLETED","status_verified_date":"2023-09","start_date":"2021-09-01","start_date_type":"ACTUAL","primary_completion_date":"2021-10-25","primary_completion_date_type":"ACTUAL","completion_date":"2021-10-25","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["HLN"]}